MedTrace Logo

Norepinephrine Addition in Spinal Anesthesia of Caesarean Section

NCT03626454 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-11-26

No results posted yet for this study

Summary

The objective is to compare efficacy of prophylactic norepinephrine bolus versus Infusion in prevention of hypotension which occurs frequently after spinal anesthesia for caesarean section. The authors hypothesize that prophylactic norepinephrine bolus is as effective as infusion in Prevention of hypotension after spinal anesthesia in caesarean section

Conditions

  • Hypotension Drug-Induced

Interventions

DRUG

Norepinephrine Bolus

'Norepinephrine Bitartarte' bolus of 6 µg/mL for 30 seconds immediately after intrathecal injection

DRUG

Norepinephrine infusion

an infusion of 6 µg/mL norepinephrine that was started at 6 µg/kg/h immediately after intrathecal injection

DRUG

Normal Saline Flush, 0.9% Injectable Solution

10 ml normal saline in syringe for bolus for 30 seconds immediately after intrathecal injection

DRUG

Normal Saline 0.9% Infusion Solution

50 ml syringe with normal saline infuse at a rate 1ml/kg/h immediately after intrathecal injection

Sponsors & Collaborators

  • Fayoum University Hospital

    lead OTHER

Principal Investigators

  • Hany M Yassin, M.D. · Fayoum University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-16
Primary Completion
2024-01-01
Completion
2024-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03626454 on ClinicalTrials.gov